ClinicalTrials.Veeva

Menu

The Use of Virtual Reality for the Treatment of Visual Vertigo.

NHS Foundation Trust logo

NHS Foundation Trust

Status

Unknown

Conditions

Treatment of Visual Vertigo

Treatments

Other: Virtual environment with fast moving objects
Other: Virtual environment with no movement

Study type

Interventional

Funder types

Other

Identifiers

NCT03020654
STH19451
5375 (Other Identifier)

Details and patient eligibility

About

This study investigates the use of virtual environments presented on a head mounted display for the rehabilitation of those suffering with visual vertigo.

The control group and treatment groups will be presented with two different sets of environments and be given the same head and eye exercises to complete within the environment. They will also be provided with at home exercises to complete.

Full description

Visual vertigo occurs after the balance system suffers damage (e.g after a viral infection such as labyrinthitis). This causes an over-reliance on the eyes to maintain balance which causes disorientation in busy environments such as the supermarket. The treatment involves trying to desensitise the individual to visually stimulating situations. Further head and eye exercises are completed alongside the exposure to overcome the damage done to the balance system.

Enrollment

18 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Those who have been diagnosed with visual vertigo and have scored a significant level on the Situational Characteristic Questionnaire (over 0.74 as per Pavlou et al., 2006).

Exclusion criteria

  • Those with or under investigation for epilepsy.
  • Those who have been determined to have no or limited balance function in both ears.
  • Those with reduced visual acuity that will leave them unable to view the 3D effects of the head mounted display.
  • Those with severe mental health disorders e.g. psychosis, paranoid disorders, bipolar disorder or a history of substance abuse.
  • Severe neck pain/ restricted movement.
  • Previous treatment for visual vertigo.
  • Those with an fluctuating vestibular disorder such as Ménière's disease or vestibular migraine.
  • Those with untreated Benign Paroxymal Positional Vertigo (BPPV).
  • Those with a significant brain injury, or head injury that results in a central vestibular disorder.
  • Those with an arrhythmia.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

18 participants in 2 patient groups

Treatment group
Experimental group
Description:
Virtual environment with fast moving objects these are graded in intensity from 1-7. Participants complete head and eye exercises within the environment using focus points such as benches and lanterns for a six week treatment program.
Treatment:
Other: Virtual environment with fast moving objects
Control group
Active Comparator group
Description:
Virtual environment with no movement graded at grade 0. Participants complete head and eye exercises within the environment using focus points such as benches and lanterns for a six week treatment program.
Treatment:
Other: Virtual environment with no movement

Trial contacts and locations

1

Loading...

Central trial contact

Kirsty M Walker, BSc; Paul Bacon, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems